Neupogen Market, By Indication (Chemotherapy-induced neutropenia in non-myeloid malignancies, Neutropenia in acute myeloid leukemia (AmL) patients post induction or consolidation chemotherapy, Neutropenia post-myeloablative chemotherapy followed by bone marrow transplantation (BMT), Mobilization of autologous hematopoietic progenitor cells for leukapheresis, Chronic neutropenia (congenital, cyclic, idiopathic), and Hematopoietic Syndrome of Acute Radiation Syndrome (H-ARS)), By Dose Strength (300mcg/1mL, 480mcg/1.6mL, 300MGC/0.5mL, and 480mcg/0.8mL), By Packaging (Single-use vials and Prefilled syringes), By Patient Age Group (Pediatric, Adult, and Geriatric), By Sales Channel (Online and Offline), By End User (Hospitals, Oncology Clinics, Ambulatory Surgical Centers, and Others (Academic & Research Institutions, etc.)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
Select a License Type that Suits your Business Needs
US$ 2,000
Two thousand dollars
Single User License
( Full Report )
US$ 4,500
US$ 3,000
Three thousand dollars
Frequently purchased
Multi User License
( Full Report )
US$ 7,000
US$ 5,000
Five thousand dollars
Corporate User License
( Full Report )
US$ 10,000
US$ 6000
Six thousand dollars
Client Testimonials
Client Testimonials
Our Clients
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

860519526
9001:2015
27001:2022